192 related articles for article (PubMed ID: 33613848)
1. Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors.
Manem VSK; Sazonova O; Gagné A; Orain M; Khoshkrood-Mansoori B; Gaudreault N; Bossé Y; Joubert P
Oncotarget; 2021 Feb; 12(3):209-220. PubMed ID: 33613848
[TBL] [Abstract][Full Text] [Related]
2. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts.
Sazonova O; Manem V; Orain M; Khoshkrood-Mansoori B; Gaudreault N; Desmeules P; Bossé Y; Joubert P
Mod Pathol; 2020 Sep; 33(9):1712-1721. PubMed ID: 32291397
[TBL] [Abstract][Full Text] [Related]
4. Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors.
Manem VSK; Sazonova O; Gagné A; Orain M; Khoshkrood-Mansoori B; Gaudreault N; Bossé Y; Joubert P
Oncotarget; 2022 Dec; 13():1302. PubMed ID: 36473123
[No Abstract] [Full Text] [Related]
5. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 is a powerful tool for grading neuroendocrine tumors among Egyptian patients: a 10-year experience.
Salama A; Badawy O; Mokhtar N
J Cancer Res Clin Oncol; 2014 Apr; 140(4):653-61. PubMed ID: 24515911
[TBL] [Abstract][Full Text] [Related]
7. The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms.
Pelosi G; Travis WD
Pathologica; 2021 Oct; 113(5):377-387. PubMed ID: 34837096
[TBL] [Abstract][Full Text] [Related]
8. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
[TBL] [Abstract][Full Text] [Related]
9. Recent updates on grading and classification of neuroendocrine tumors.
Kim JY; Hong SM; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
11. Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms.
Rubino M; Scoazec JY; Pisa E; Faron M; Spaggiari L; Hadoux J; Spada F; Planchard D; Cella CA; Leboulleux S; De Marinis F; Ducreux M; Lamartina L; Baudin E; Fazio N
Lung Cancer; 2020 Oct; 148():149-158. PubMed ID: 32916569
[TBL] [Abstract][Full Text] [Related]
12. Classification of pulmonary neuroendocrine tumors: new insights.
Pelosi G; Sonzogni A; Harari S; Albini A; Bresaola E; Marchiò C; Massa F; Righi L; Gatti G; Papanikolaou N; Vijayvergia N; Calabrese F; Papotti M
Transl Lung Cancer Res; 2017 Oct; 6(5):513-529. PubMed ID: 29114468
[TBL] [Abstract][Full Text] [Related]
13. Classification of lung neuroendocrine tumors: lights and shadows.
Volante M; Gatti G; Papotti M
Endocrine; 2015 Nov; 50(2):315-9. PubMed ID: 25795289
[TBL] [Abstract][Full Text] [Related]
14. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.
Fabbri A; Cossa M; Sonzogni A; Papotti M; Righi L; Gatti G; Maisonneuve P; Valeri B; Pastorino U; Pelosi G
Virchows Arch; 2017 Feb; 470(2):153-164. PubMed ID: 28054150
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases.
Carlinfante G; Baccarini P; Berretti D; Cassetti T; Cavina M; Conigliaro R; De Pellegrin A; Di Tommaso L; Fabbri C; Fornelli A; Frasoldati A; Gardini G; Losi L; Maccio L; Manta R; Pagano N; Sassatelli R; Serra S; Camellini L
Virchows Arch; 2014 Jul; 465(1):49-55. PubMed ID: 24807732
[TBL] [Abstract][Full Text] [Related]
17. Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas.
Matheus RS; Bernardi Fdel C; Gallo CP; da Silva AP; Rodrigues OR; Capelozzi M; Lopes A; Fenezelian S; Saldiva PH; Capelozzi VL
Pathol Res Pract; 2004; 200(1):13-23. PubMed ID: 15157046
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Tumor Stage on the Prognostic Value of Ki-67 Index and Mitotic Count in Small Intestinal Neuroendocrine Tumors.
Sun Y; Lohse C; Smyrk T; Hobday T; Kroneman T; Zhang L
Am J Surg Pathol; 2018 Feb; 42(2):247-255. PubMed ID: 29016403
[TBL] [Abstract][Full Text] [Related]
19. Grading of pancreatic neuroendocrine tumors on endoscopic ultrasound-guided fine-needle aspiration using Ki-67 index and 2017 World Health Organization criteria: An analysis of 32 cases.
Kalantri S; Bakshi P; Verma K
Cytojournal; 2020; 17():21. PubMed ID: 33093857
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumor G3 of bronchopulmonary origin and its classification.
Kasajima A; Klöppel G
Pathol Int; 2022 Oct; 72(10):488-495. PubMed ID: 35983917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
